Dolutegravir in pregnant mice is associated with increased rates of fetal defects at therapeutic but not at supratherapeutic levels
Evaluating gross fetal anomalies in pregnant mice randomly assigned to control, or DTG-based ART at doses yielding therapeutic, or supra-therapeutic DTG levels
View Publication